| 28 | 0 | 62 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 探讨盆腔脓肿女性患者真菌感染危险因素并评估各因素的预测效能。方法 本研究为前瞻性、观察性研究,以2021年2月—2025年1月在武汉市第一医院妇产科住院治疗的255例盆腔脓肿女性患者作为研究对象。入组患者根据治疗过程中是否并发真菌感染被划分为并发真菌感染组和未并发真菌感染组。对比两组患者一般临床资料、盆腔脓肿相关因素、治疗相关因素、常规检验指标的差异。通过多因素logistic回归分析筛选与盆腔脓肿女性患者并发真菌感染风险相关的独立影响因素,绘制受试者工作特征曲线(receiver operating characteristic curve,ROC)分析各影响因素联合预测患者并发真菌感染的价值。结果 入组的盆腔脓肿女性患者年龄范围23~69岁,中位年龄42(37,50)岁,其中并发真菌感染44例,并发真菌感染率为17.3%。并发真菌感染组患者年龄、合并糖尿病占比、营养不良占比、最高体温、脓肿大小、病程、应用糖皮质激素占比、应用性激素药物占比、留置导尿管占比、使用抗生素时间、使用抗生素种类、碳青霉烯类使用占比、治疗前中性粒细胞计数、C反应蛋白、降钙素原、红细胞沉降率均高于未并发真菌感染组患者,白蛋白、IgG均低于未并发真菌感染组患者(P<0.05)。多因素logistic回归分析提示年龄、营养不良、脓肿大小、应用糖皮质激素、使用抗生素时间、使用抗生素种类、中性粒细胞计数、ESR均是盆腔脓肿女性患者并发真菌感染风险的独立危险因素,Ig G是盆腔脓肿女性患者并发真菌感染风险的独立保护因素(P<0.05)。ROC曲线分析表明,上述9种影响因素联合预测盆腔脓肿女性患者并发真菌感染风险的曲线下面积95%CI为0.847(0.785~0.909),灵敏度为84.53%、特异度为80.25%。结论 年龄、营养不良、脓肿大小、应用糖皮质激素、抗生素使用情况、中性粒细胞计数、红细胞沉降率及IgG均是盆腔脓肿女性患者并发真菌感染的影响因素,基于上述指标可有效预测患者并发真菌感染风险。
Abstract:Objective To explore the risk factors for fungal infections in female patients with pelvic abscesses and evaluate the predictive efficacy of each factor. Methods This study was a prospective, observational study. A total of 255 female patients with pelvic abscesses who were hospitalized in the Department of Obstetrics and Gynecology of Wuhan No.1 Hospital from February 2021 to January 2025 were enrolled as the research subjects. The enrolled patients were divided into a group with concurrent fungal infection and a group without concurrent fungal infection according to whether they had a concurrent fungal infection during the treatment process. The differences in general clinical data, factors related to pelvic abscesses, treatment-related factors, and routine laboratory test indicators between the two groups of patients were compared. Multivariate logistic regression analysis was used to screen the independent influencing factors related to the risk of concurrent fungal infection in female patients with pelvic abscesses. The receiver operating characteristic(ROC) curve was plotted to analyze the value of the combined prediction of concurrent fungal infection in patients by each influencing factor. Results The age range of the enrolled female patients with pelvic abscesses was 23 to 69 years old, and the median age was 42(37, 50) years old. Among them, 44 cases had concurrent fungal infections, and the incidence of concurrent fungal infections was 17.3%. The age, proportion of patients with diabetes mellitus, proportion of patients with malnutrition, maximum body temperature, abscess size, course of disease, proportion of patients using glucocorticoids, proportion of patients using sex hormone drugs, proportion of patients with indwelling urinary catheters, duration of antibiotic use, types of antibiotics used, proportion of carbapenem use, neutrophil count before treatment, C-reactive protein, procalcitonin and erythrocyte sedimentation rate(ESR) in the group with concurrent fungal infection were all higher than those in the group without concurrent fungal infection, while the albumin(ALB) and IgG were lower than those in the group without concurrent fungal infection(P<0.05). Multivariate logistic regression analysis indicated that age, malnutrition, abscess size, use of glucocorticoids, duration of antibiotic use, types of antibiotics used, neutrophil count, and ESR were all independent risk factors for the risk of concurrent fungal infection in female patients with pelvic abscesses, and IgG was an independent protective factor for the risk of concurrent fungal infection in female patients with pelvic abscesses(P<0.05). ROC curve analysis showed that the area under the curve(95% CI) of the combined prediction of the risk of concurrent fungal infection in female patients with pelvic abscesses by the above 9 influencing factors was 0.847(0.785-0.909), with a sensitivity of 84.53% and a specificity of 80.25%. Conclusion Age, malnutrition, abscess size, use of glucocorticoids, antibiotic use, neutrophil count, ESR, and IgG are all influencing factors for concurrent fungal infection in female patients with pelvic abscesses. Based on the above indicators, the risk of concurrent fungal infection in patients can be effectively predicted.
[1]中华医学会妇产科学分会感染性疾病协作组,薛凤霞,刘朝晖,等.盆腔脓肿诊治中国专家共识(2023年版)[J].中国实用妇科与产科杂志, 2023, 39(12):1210-1216.
[2]张潇洁,牛战琴.盆腔脓肿的诊治进展[J].中国生育健康杂志,2020, 31(5):500-502.
[3]卜云芸,钟素梅.某院妇科恶性肿瘤患者术后盆腔感染的发生情况及其病原学特征分析[J].抗感染药学, 2024, 21(6):649-652.
[4]李雪,项玉涵,李伟霞,等.女性阴道分泌物真菌感染现状研究进展[J].医学检验与临床, 2024, 35(5):46-50.
[5]Ran?elovi?M, Dimitrijevi?M, Mijatovi?S, et al. Antifungal susceptibility and biofilm production of Candida species-causative agents of female genital tract infections[J]. Braz J Microbiol, 2024,55(4):3863-3872.
[6]Soga K, Sai A, Kitae H. Efficacy of endoscopic ultrasound-guided pelvic abscess drainage for pelvic abscesses:A case series study[J].Arab J Gastroenterol, 2023, 24(3):149-154.
[7]曹娟娟,张华玲,黄丽英,等.盆腔放线菌病3例报告及文献分析[J].临床医学进展, 2021, 11(11):5089-5094.
[8]中国妇幼保健协会放射介入专业委员会,中国医师协会微无创医学专业委员会,中华预防医学会生殖健康分会.盆腔脓肿介入治疗专家共识(2021年版)[J].中国实用妇科与产科杂志,2021, 37(12):1214-1219.
[9]Zhou X, Liu J, Zhang Q, et al. Comparison of the suitability between NRS2002 and MUST as the first-step screening tool for GLIM criteria in hospitalized patients with GIST[J]. Front Nutr,2022, 9:864024. DOI:10.3389/fnut.2022.864024.
[10]聂玲玲,张莉.急诊危重症患者真菌感染的菌种和药敏分析及其易感因素研究[J].中国真菌学杂志, 2024, 19(5):451-457.
[11]曹振华,王蕾,魏永洁.老年COPD患者外周血辅助性T细胞17/调节性T细胞失衡对继发真菌感染的影响[J].中国老年学杂志, 2022, 42(23):5693-5696.
[12]周士飞,高艳玲,唐世杰.预后营养指数联合T淋巴细胞亚群对AECOPD继发性肺部真菌感染的预测价值分析[J].四川医学,2024, 45(10):1130-1135.
[13]邢琳,陈微微.老年肺癌患者继发侵袭性真菌感染的危险因素及预后分析[J].老年医学与保健, 2023, 29(5):960-963.
[14]Goldberg JL, Giantini-Larsen A, Brennan CW. Fungal abscess in the brain[J]. World Neurosurg, 2022, 158:216-217. DOI:10.1016/j.wneu.2021.12.002.
[15]蒲宝平,岳建玲,周步琴.超声引导下穿刺抽脓术与超声引导下置管引流冲洗术治疗不同脓腔直径乳腺脓肿的效果对比研究[J].临床和实验医学杂志, 2024, 23(7):767-772.
[16]Das A, Ramasamy K, Thangavel S, et al. Internal drainage of retropharyngeal abscess secondary to esophageal foreign bodies:a case series[J]. Eur Arch Otorhinolaryngol, 2022, 279(2):955-959.
[17]García EG, de Miguel Manso S, Tejedor JG, et al. Transcervical drainage of abdominal-pelvic abscess after laparoscopic sacrocolpopexy[J]. Int Urogynecol J, 2021, 32(3):581-585.
[18]李佳荣,张纪岩.糖皮质激素对免疫细胞调控的研究进展[J].中国免疫学杂志, 2024, 40(1):31-36.
[19]Cheng Y, Chen H, Duan P, et al. Early depletion of M1 macrophages retards the progression of glucocorticoid-associated osteonecrosis of the femoral head[J]. Int Immunopharmacol, 2023, 122:110639.DOI:10.1016/j.intimp.2023.110639.
[20]王子豪,李凌浩,薛胜利,等. B淋巴细胞肿瘤患者接受CAR-T细胞治疗后巨细胞病毒再激活及其影响因素[J].中华血液学杂志, 2024, 45(11):1005-1009.
[21]张萍.国产与进口雌激素软膏治疗绝经后妇女萎缩性阴道炎效果及对阴道微环境、性激素影响[J].中国计划生育学杂志,2022, 30(4):757-760.
[22]Drummond RA, Desai JV, Ricotta EE, et al. Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria[J]. Cell Host Microbe, 2022, 30(7):1020-1033.e6.
[23]Seelbinder B, Chen J, Brunke S, et al. Antibiotics create a shift from mutualism to competition in human gut communities with a longerlasting impact on fungi than bacteria[J]. Microbiome, 2020, 8(1):133.
[24]Picot S, Beugnet F, Leboucher G, et al. Drug resistant parasites and fungi from a one-health perspective:A global concern that needs transdisciplinary stewardship programs[J]. One Health, 2022, 14:100368. DOI:10.1016/j.onehlt.2021.100368.
[25]Pereira M, Rao K, Sharin F, et al. Topical antibiotic-induced otomycosis-a systematic review of aetiology and risk factors[J].Indian J Otolaryngol Head Neck Surg, 2024, 76(5):3766-3776.
[26]Rutkowska E, KwiecieńI, Raniszewska A, et al. New neutrophil parameters in diseases with various inflammatory processes[J].Biomedicines, 2024, 12(9):2016.
[27]Tomassetti F, Calabrese C, Bertani F, et al. Performance evaluation of automated erythrocyte sedimentation rate(ESR)analyzers in a multicentric study[J]. Diagnostics(Basel), 2024, 14(18):2011.
[28]Doron I, Kusakabe T, Iliev ID. Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity[J]. Semin Immunol,2023, 67:101757.DOI:10.1016/j.smim.2023.101757.
基本信息:
中图分类号:R711.3
引用信息:
[1]张璇,刘丽丹,吕玮.盆腔脓肿女性患者真菌感染危险因素及预测效能评估[J].中国真菌学杂志,2025,20(06):617-623.
2025-12-28
2025-12-28